Journal
NEUROBIOLOGY OF DISEASE
Volume 98, Issue -, Pages 137-148Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2016.12.004
Keywords
PAK3; Differentiation; Oligodendrocyte; OPC; Intellectual disability; Myelin; Development
Categories
Funding
- Universite Pierre et Marie Curie
- Centre National de la Recherche Scientifique
- Royal Society [JP090037]
- La fondation Jerome Lejeune [1070-BJ2012B, 1547-NB2016A]
- Institut des Neurosciences translationnelles de Paris (IHU-A-ICM) [ANR-10-IAIUH-06]
- [ANR-07-NEURO-043-01]
Ask authors/readers for more resources
Oligodendrocyte and myelin deficits have been reported in mental/psychiatric diseases. The p21-activated kinase 3 (PAK3), a serine/threonine kinase, whose activity is stimulated by the binding of active Rac and Cdc42 GTPases is affected in these pathologies. Indeed, many mutations of Pak3 gene have been described in non-syndromic intellectual disability diseases. Pak3 is expressed mainly in the brain where its role has been investigated in neurons but not in glial cells. Here, we showed that PAK3 is highly expressed in oligodendrocyte precursors (OPCs) and its expression decreases in mature oligodendrocytes. In the developing white matter of the Pak3 knockout mice, we found defects of oligodendrocyte differentiation in the corpus callosum and to a lesser extent in the anterior commissure, which were compensated at the adult stage. In vitro experiments in OPC cultures, derived from Pak3 knockout and wild type brains, support a developmental and cell-autonomous role for PAK3 in regulating OPC differentiation into mature oligodendrocytes. Moreover, we did not detect any obvious alterations of the proliferation or migration of Pak3 null OPCs compared to wild type. Overall, our data highlight PAK3 as a new regulator of OPC differentiation. (C) 2016 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available